The outcome of an investigation into ‘matters that had been raised’ about the FMA chair will be released ‘shortly’.
Construction on first NZ site, announced in June 2021, is ‘well under way’.
Figure undisclosed but a ‘wonderful completion’ says major Kiwi shareholder.
While Covid curbed its New Zealand enthusiasm, Australia charged ahead.
Sick and isolating staff a big concern for already struggling sector.
Receivers expect to retire from role in next six months.
US backer refusing to co-operate saying it is ‘outside NZ jurisdiction’.
Nano-textile ‘ingredient manufacturer’ (ex-Revolution Fibres) has unicorn-sized ambitions.
The deal is understood to be the largest in the country's burgeoning medical cannabis industry.
UPDATE: Seeka to pay 13c/share full-year dividend in February.